Radiopharmaceuticals and Tracers

A new four-year research study will determine the clinical usefulness and value of a brain positron emission tomography (PET) scan in diagnosing Alzheimer’s and other dementias. The $100 million Imaging Dementia – Evidence for Amyloid Scanning (ID...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

prostate cancer, recurrence, PET/CT, PSMA-ligand, Matthias Eiber, Ga-68
The novel Ga-68-PSMA-ligand positron emission tomography/computed tomography (PET/CT) has substantially higher detection rates of prostate-specific membrane...
Ipsen, OctreoPharm Sciences, acquisition, NET, radioactive-labeled compound
Ipsen announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life sciences company developing innovative radioactive-labeled...
Cancer Targeted Technology (CTT), announced that it was awarded a NIH two-year, $2 million Small Business Innovation Research (SBIR) grant. The funds will be...
Mo-99, molybdenum, MURR, NorthStar, production, University of Missouri
NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 (Mo-99) aliquoting system installed at the...
Navidea Biopharmaceuticals' Inc. Lymphoseek (technetium Tc 99m tilmanocept) injection is U.S. Food and Drug Administration (FDA)-
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the...
The U.S. Food and Drug Administration (FDA) designated the Society of Nuclear Medicine and Molecular Imaging's (SNMMI's) ...

Articles

light therapy, radiation oncology, radiopharmaceuticals, PET
Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis have devised a way to apply light-based therapy to deep...
The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based imaging agent jointly developed at Washington...
Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...

Video Center

A battle is taking shape in computed tomography (CT), one that pits the tubes that deliver X-...
3 weeks 3 days ago
The ITN team has just returned from the Healthcare Information and Management Society’s (HIMSS15)...
3 weeks 3 days ago
U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
5 weeks 2 hours ago
The webinar Maximize Your Clinical Imaging With a VNA Strategy will explain the changing face of medical imaging and data, and the challenges to...
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...

Comparison Charts

Sorry there is no data available